xCures aims to improve the outcomes of patients with cancer using real world data (RWD) tools. Quickly identifying relevant patient populations is a critical first step in understanding market access challenges and a drug’s efficacy in the real world, among other applications. xCures has created an observational registry that includes patient records and provides treatment recommendations, allowing for a single source of RWD in longitudinal oncology studies.
“If we can identify early on the patients taking new, exciting therapies and empower them to share their data, we can begin tracking them in a real-world setting and begin gathering real-world outcomes data from them much earlier than we’re typically used to. This is a win-win for everyone.” Read more here.
(Source: Scientist.com, 11/2/21)